Inventor
STEIDLER LOTHAR
BE28 patents
⚠️ This page may combine multiple inventors who share the name “STEIDLER LOTHAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTREXON ACTOBIOTICS NV
10 patentsUS9347036B2May 24, 2016
Modified gram positive bacteria and uses thereof
INTREXON ACTOBIOTICS NV4 citations82
US10519418B2Dec 31, 2019
Modified gram positive bacteria and uses thereof
INTREXON ACTOBIOTICS NV1 citations71
US10030234B2Jul 24, 2018
Modified gram positive bacteria and uses thereof
INTREXON ACTOBIOTICS NV2 citations71
US9982228B2May 29, 2018
Modified gram positive bacteria and uses thereof
INTREXON ACTOBIOTICS NV2 citations71
US12359210B2Jul 15, 2025
Genetically modified bacteria stably expressing IL-10 and insulin
INTREXON ACTOBIOTICS NV0 citations61
US10988770B2Apr 27, 2021
Polycistronic expression system for bacteria
INTREXON ACTOBIOTICS NV0 citations60
US11633438B2Apr 25, 2023
Cryoprotectants for freeze drying of lactic acid bacteria
INTREXON ACTOBIOTICS NV0 citations59
US10793825B2Oct 6, 2020
Modified gram positive bacteria and uses thereof
INTREXON ACTOBIOTICS NV0 citations50
US9458467B2Oct 4, 2016
Modified gram positive bacteria and uses thereof
INTREXON ACTOBIOTICS NV0 citations50
US10596207B2Mar 24, 2020
Cryoprotectants for freeze drying of lactic acid bacteria
INTREXON ACTOBIOTICS NV0 citations48
INTREXON ACTOBIOTICS N V
8 patentsUS10905727B2Feb 2, 2021
Compositions and methods for the treatment of type 1 diabetes
INTREXON ACTOBIOTICS N V7 citations83
US11786567B2Oct 17, 2023
Compositions and methods for the treatment of type 1 diabetes
INTREXON ACTOBIOTICS N V2 citations72
US10858663B2Dec 8, 2020
Genetically modified bacteria stably expressing IL-10 and insulin
INTREXON ACTOBIOTICS N V3 citations72
US11384123B2Jul 12, 2022
Mucoadhesive microorganism
INTREXON ACTOBIOTICS N V2 citations71
US10808014B2Oct 20, 2020
Mucoadhesive microorganism
INTREXON ACTOBIOTICS N V4 citations71
US12252516B2Mar 18, 2025
Mucoadhesive microorganism
INTREXON ACTOBIOTICS N V0 citations61
US12246046B2Mar 11, 2025
Compositions and methods for the treatment of type 1 diabetes
INTREXON ACTOBIOTICS N V0 citations61
US11549118B2Jan 10, 2023
Genetically modified bacteria stably expressing IL-10 and insulin
INTREXON ACTOBIOTICS N V0 citations61
VLAAMS INTERUNIV INST BIOTECH
4 patentsUS6605286B2Aug 12, 2003
Delivery of biologically active polypeptides
VLAAMS INTERUNIV INST BIOTECH82 citations95
US6746671B2Jun 8, 2004
Use of a cytokine-producing lactococcus strain to treat colitis
VLAAMS INTERUNIV INST BIOTECH62 citations94
US6190662B1Feb 20, 2001
Materials and methods relating to the attachment and display of substances on cell surfaces
VLAAMS INTERUNIV INST BIOTECH32 citations90
US7220418B1May 22, 2007
Delivery of trefoil peptides
VLAAMS INTERUNIV INST BIOTECH23 citations87